Christoph Rademacher is one of five innovators to the 2021 NIBR Global Scholars Program. Since September 2020 he is Professor of Molecular Drug Targeting at the Department of Pharmaceutical Chemistry and the Department of Microbiology, Immunobiology and Genetics at the University of Vienna. His research areas include Targeted Delivery, Drug Discovery, Structural Biology and Immunology. 

He is honored to be one of the innovators: “For us, this award means on the one hand that our research is recognized as translational and on the other hand, with this funding, we also get the budget to do research on a topic that is extremely exciting and forward-looking. We hope to use the results of this research to deliver new mRNA-based drugs, not just vaccines, to the right target. with this, we would increase their efficiency, reduce side effects and enable fundamentally new therapeutic approaches."

We congratulate Christoph Rademacher and his team!